Drug Database
Back to search

Belgium· BE-AMP-SAM665802-00

Aqneursa 1 g

A levacetylleucine product containing levacetylleucine, registered in Belgium by IntraBio Ireland Limited. The same ATC class is registered in 7 of our 19 countries.

ATC N07XX27

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAqneursa 1 gATCN07XX27REGISTER NO.BE-AMP-SAM665802-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levacetylleucineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levacetylleucine is registered in 7 of 19 countries.

Countries holding a registration under ATC N07XX27 (levacetylleucine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search levacetylleucine products by name

Levacetylleucine · ATC N07XX27

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Levacetylleucine
Manufacturer
IntraBio Ireland Limited
Country
Belgium (BE)
ATC code
N07XX27
ATC class
Levacetylleucine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levacetylleucine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levacetylleucine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Aqneursa
  • Liechtenstein · Aqneursa
  • Norway · Aqneursa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/034c0cd5-3acb-41c7-92ae-83009ba26057
GET /v1/drugs/034c0cd5-3acb-41c7-92ae-83009ba26057?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granules for oral suspension in sachet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Aqneursa 1 g",
  "name_fr": "Aqneursa 1 g",
  "name_nl": "Aqneursa 1 g",
  "amp_code": "SAM665802-00",
  "strengths": [
    "1.0000",
    "1.0000",
    "642.2000",
    "0.1530"
  ],
  "pack_count": 2,
  "substances": [
    "Levacetylleucine",
    "Isomalt",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Levacetylleucine",
  "authorisation_numbers": [
    "EU/1/25/1928/001",
    "EU/1/25/1928/002"
  ]
}
API referenceMCP serverPlans

See everything about levacetylleucine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console